KANSL1 and uterine carcinosarcoma: CRHR1-KANSL1 fusions were reported in 5% of TCGA's colorectal tumors (16 of 312 analyzed), and 3.5% of TCGA's uterine carcinosarcomas (2 of 57 analyzed) [12].